Azilsartan medoxomil in the management of hypertension: an evidence-based review of its place in therapy

Conclusion: Azilsartan is a safe and effective treatment option for every stage of hypertension, both alone or in fixed-dose combination tablets with chlorthalidone or amlodipine. Beneficial effects of AZI were also noted in patients with any degree of renal impairment. In addition, safety profiles of AZI were similar to that of the placebo. Keywords: hypertension, pharmacology, azilsartan, blood pressure, pharmacokinetics, cost-effectiveness
Source: Core Evidence - Category: Drugs & Pharmacology Tags: Core Evidence Source Type: research